YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI3K/AKT/mTOR pathway

Meixu Wan(Tianjin Institute of Pharmaceutical Research (China)), Xiangbo Gou(Tianjin University of Technology), Kunkun Yin(ZheJiang Institute For Food and Drug Control), Shiyan Ma(Tianjin University of Technology), Qing Xu(Hebei University of Chinese Medicine), Hui Gao(Tiangong University), De‐Kun Li(Kaiser Permanente), Jing Yuan(Sun Yat-sen University)
Journal of Ethnopharmacology
November 16, 2021
10.1016/j.jep.2021.114835
Cited by 37

Related Papers

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
|Nature|2016|925
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene
|Cancer Cell|2004|379
The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival
|Nature|2017|354
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304